So, with their recent swoon, I am wondering if we are witnessing a repeat of last year, where the Red Sox came into the season with a roster that kind of relied on health and guys having career years to be competitive.
2021 was the blueprint. They got great pitching performances out of everybody but Sale and career years out of guys like Hernandez and Renfroe. Most important of all they stayed healthy. And they almost pulled it off.
Last season, they more or less tried to run it back and after stumbling at the start, looked great until the injuries kicked in and fell apart around July.
This season, they seemed to be firing on all cylinders until you had sort of a perfect storm of Jansen blowing two saves, the horrible West Coast road trip where the offense dried up and Sale going down.
My issue with this approach is that they are relying on guys to stay healthy and play to their ceiling, not their mean (or average or whatever it is). Obviously that opens the door for the Shaughnessy‘s of the world to argue that they are just being cheap or trying to outsmart everyone.But that’s just noise. More importantly, it’s hard to sustain in a division where all four competitors are putting real lineups on the field.
I also wonder whether psychologically that opens them up for long dips in the quality of their play because all the guys start playing a little tight, knowing that they have to play at their best for the team just to keep up.
It’s a little bit of a bummer as a fan, because I actually like this collection of players and can appreciate the desire not just to sign everybody at the biggest dollar figure. But it seems hard to compete consistently.
I think 2021 was a good bridge-year template: a competitive club if it all works out to a certain point. The 2021 club stayed within striking distance and traded for Schwarber/Robles/Davis in late July to address shortcomings on the club. Also, they expected Sale to come back and chip in (which he did.)
So I don't think the 2021 "relied" on health, or outlier years. In fact, they didn't really get much in the way of planned supporting performances from: Gonzalez/Cordero/Santana. Instead they got rando Covid-Replacement final flares out of Shaw and Iglesias, and Dalbec had a mostly-up season of ups and downs, while Hernandez was probably the only outlier in terms of positive performance. So a bit of bad luck, and a bit of good.
In 2022, I think there was an expectation that Sale would be part of the rotation and Paxton would be the late season entrance. That didn't happen, and so the Sox had less of a deep base to push from. However, they got some great short term value out of Wacha and Strahm, et al. Until injuries derailed even that and they had to go deep into the emergency player level, starting Crawford and Winckowski for 26 games.
I'd say the 2022 season made much better supporting talent choices to start with, but Dalbec and Hernandez (injured) regressed significantly. The one big miss was JBJ. I don't think they so much "relied" on health - but they were absolutely pole-axed by bad health outcomes. Sale had his cursed season. Paxton never came on board. Story blew out his elbow. All the starters went on the IL for a stretch. 2022 was devastated by injuries - to the point where "relying" on average health went out the window. Still, they hung in there, which resulted in a bit of lateraling at the trading deadline. Diekman for McGuire, Northcut for Pham, Vazquez for Valdez and Abreu, Groom for Hosmer/Fergeson/Roiser.
As an aside, I must note: Wacha, Strahm, Hill, Eovaldi - those guys everyone seems to think we missed out on? They all spent significant time on the IL. Wacha - 23 starts, Hill - 26, Eovaldi - 20. There was endless pissing and moaning that it was insane to sign old and often injured guys.
This year the main problem is the starting pitching has been, collectively, a disaster. I'm not sure how much of it was foreseeable, but I don't think anyone thought the Sox should have expected Houck and Whitlock to regress while Kluber and Pivetta collapsed. Meanwhile Bello's ERA is better but his FIP is much worse. I think if there were "normal trends" there, the Sox would be in the middle of the AL East scrum. (That includes just one AAA guy taking a step forward to perhaps help out the club in the bullpen.)
At the end of the day you're simply not going to get 100% of the calls on players correct. Bloom/Bush and Company have ID'd some under-appreciated pitchers in the past few years, and have been able to get some performances out of many of them. I don't know what went wrong this year, but the breadth of it is troubling.
As a final thought - in 2021 we scored the 4th most runs in the AL, in 2022 we scored the 4th most runs in the AL, and in 2023, we sit at the 3rd most as of today.